CORCEPT THERAPEUTICS INC - COMMON STOCK (CORT)

CUSIP: 218352102

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / COMMON STOCK
Shares outstanding
106,815,676
Total 13F shares
87,458,593
Share change
-3,510,076
Total reported value
$1,027,102,142
Put/Call ratio
97%
Price per share
$11.74
Number of holders
202
Value change
-$43,866,557
Number of buys
83
Number of sells
113

Quarterly Holders Quick Answers

What is CUSIP 218352102?
CUSIP 218352102 identifies CORT - CORCEPT THERAPEUTICS INC - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of CORT - CORCEPT THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock Finance, Inc.
13F
Company
15%
15,529,665
$207,477,000 31 Dec 2018
13F
FEDERATED HERMES, INC.
13F
Company
11%
11,604,789
$155,040,000 31 Dec 2018
13F
VANGUARD GROUP INC
13F
Company
10%
10,773,994
$143,940,000 31 Dec 2018
13F
INGALLS & SNYDER LLC
13F
Company
7.8%
8,373,889
$111,875,000 31 Dec 2018
13F
Consonance Capital Management LP
13F
Company
5.8%
6,211,964
$82,992,000 31 Dec 2018
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
4.4%
4,647,209
$62,087,000 31 Dec 2018
13F
STATE STREET CORP
13F
Company
2.8%
2,942,351
$39,310,000 31 Dec 2018
13F
Invesco Ltd.
13F
Company
2%
2,186,096
$29,207,000 31 Dec 2018
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
1.8%
1,903,036
$25,424,000 31 Dec 2018
13F
MORGAN STANLEY
13F
Company
1.4%
1,463,835
$19,556,000 31 Dec 2018
13F
Bank of New York Mellon Corp
13F
Company
1.3%
1,341,941
$17,929,000 31 Dec 2018
13F
NORTHERN TRUST CORP
13F
Company
1.2%
1,302,480
$17,401,000 31 Dec 2018
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.1%
1,175,034
$15,698,000 31 Dec 2018
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.86%
915,093
$12,226,000 31 Dec 2018
13F
AMI ASSET MANAGEMENT CORP
13F
Company
0.71%
754,805
$10,084,000 31 Dec 2018
13F
NORGES BANK
13F
Company
0.66%
705,325
$9,423,000 31 Dec 2018
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.63%
668,837
$8,936,000 31 Dec 2018
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.59%
629,127
$8,405,000 31 Dec 2018
13F
S&T BANK/PA
13F
Company
0.59%
627,728
$8,387,000 31 Dec 2018
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.56%
602,493
$8,049,000 31 Dec 2018
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.54%
579,631
$7,744,000 31 Dec 2018
13F
MARSHALL WACE, LLP
13F
Company
0.54%
573,836
$7,667,000 31 Dec 2018
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.53%
562,269
$7,512,000 31 Dec 2018
13F
FMR LLC
13F
Company
0.53%
561,595
$7,503,000 31 Dec 2018
13F
D. E. Shaw & Co., Inc.
13F
Company
0.5%
530,783
$7,091,000 31 Dec 2018
13F
AJ WEALTH STRATEGIES, LLC
13F
Company
0.48%
512,169
$6,843,000 31 Dec 2018
13F
PEREGRINE CAPITAL MANAGEMENT LLC
13F
Company
0.45%
482,361
$6,444,000 31 Dec 2018
13F
STIFEL FINANCIAL CORP
13F
Company
0.44%
469,989
$6,284,000 31 Dec 2018
13F
PNC FINANCIAL SERVICES GROUP, INC.
13F
Company
0.43%
464,312
$6,203,000 31 Dec 2018
13F
ESSEX INVESTMENT MANAGEMENT CO LLC
13F
Company
0.38%
403,712
$5,394,000 31 Dec 2018
13F
OAK RIDGE INVESTMENTS LLC
13F
Company
0.36%
381,567
$5,098,000 31 Dec 2018
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.32%
343,838
$4,594,000 31 Dec 2018
13F
TEACHERS ADVISORS, LLC
13F
Company
0.28%
294,763
$3,938,000 31 Dec 2018
13F
Man Group plc
13F
Company
0.27%
291,769
$3,898,000 31 Dec 2018
13F
CITADEL ADVISORS LLC
13F
Company
0.26%
277,854
$3,712,000 31 Dec 2018
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.24%
259,270
$3,464,000 31 Dec 2018
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.23%
246,864
$3,298,000 31 Dec 2018
13F
Legal & General Group Plc
13F
Company
0.23%
241,044
$3,194,000 31 Dec 2018
13F
RHUMBLINE ADVISERS
13F
Company
0.22%
230,966
$3,086,000 31 Dec 2018
13F
HL FINANCIAL SERVICES LLC
13F
Company
0.21%
224,212
$2,995,000 31 Dec 2018
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.21%
222,750
$2,976,000 31 Dec 2018
13F
CITIGROUP INC
13F
Company
0.2%
210,293
$2,810,000 31 Dec 2018
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.19%
206,276
$2,755,000 31 Dec 2018
13F
Capital Impact Advisors, LLC
13F
Company
0.18%
193,694
$2,522,000 31 Dec 2018
13F
Swiss National Bank
13F
Company
0.17%
184,700
$2,468,000 31 Dec 2018
13F
RAYMOND JAMES & ASSOCIATES
13F
Company
0.17%
182,520
$2,438,000 31 Dec 2018
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.17%
181,379
$2,423,000 31 Dec 2018
13F
SG Americas Securities, LLC
13F
Company
0.16%
175,779
$2,348,000 31 Dec 2018
13F
QS Investors, LLC
13F
Company
0.16%
174,480
$2,332,000 31 Dec 2018
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.16%
173,024
$2,312,000 31 Dec 2018
13F

Institutional Holders of CORCEPT THERAPEUTICS INC - COMMON STOCK (CORT) as of Q1 2019

As of 31 Mar 2019, CORCEPT THERAPEUTICS INC - COMMON STOCK (CORT) was held by 202 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 87,458,593 shares. The largest 10 holders included BlackRock Inc., FEDERATED INVESTORS INC /PA/, VANGUARD GROUP INC, INGALLS & SNYDER LLC, RENAISSANCE TECHNOLOGIES LLC, Consonance Capital Management LP, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, Invesco Ltd., and Bank of New York Mellon Corp. This page lists 202 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2019 vs Q4 2018 Across Filers

Q4 2018 holders
218
Q1 2019 holders
202
Holder diff
-16
Investor Q4 2018 Shares Q1 2019 Shares Share Diff Share Chg % Q4 2018 Value $ Q1 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.